Video Shorts

Exploring the Prognostic Role of ESR1 Comutations in HR+ Breast Cancer

Who Would Play These KOLs in a Movie?

Highlighting Ongoing Research Areas for Brain Cancer

Dr Enke on Retreatment Safety With PSMA-Targeted Radioligand Therapy in mCRPC

What Should Breast Cancer Awareness Month Actually Accomplish?

Bringing Awareness to Unmet Needs in HCC Detection and Management

Spotlighting Advances and Opportunities in Brain Cancer Management

Experts Pass the Ball at ESMO 2026!

Considerations for Tile-Based Brachytherapy in Brain Tumors

Highlighting Next Steps for Liver Cancer Research

Treatment Considerations in Advanced RCC Following the Belzutifan/Lenvatinib Second-Line Approval

The OncLive Content Team Gets Creative at ESMO 2026

Choose Your Character: ESMO Edition

Previewing Key GU Oncology Data Anticipated at ESMO 2026

ESMO 2026: Looking Ahead to Targeting MTAP Loss in Pancreatic Cancer

Exploring Advances in Clinical Trial Design and FDA Collaboration

Building Clinical Trial Expertise Through OncLive’s Workshop

How the FDA Approval of Daraxonrasib Might Fuel Future Pancreatic Cancer Research

Understanding Development From Bench to Bedside

Exploring the Promise of Clinical Trials Through Inside the Trial

Strengthening Clinical Trial Education and Collaboration Through Inside the Trial

Discussing the Potential Utility of FES-PET/CT in Lobular Breast Cancer

Highlighting the HERIZON-GEA-01 Trial Update Ahead of ESMO 2026

Exploring Targeted Therapies for Endocrine-Resistant Breast Cancer

Highlighting CRC Abstracts to Watch at ESMO 2026

Discussing Neoadjuvant Chemoimmunotherapy for CRC

Exploring First-Line CDK4/6 Inhibitor Selection in Advanced Breast Cancer

Discussing the Implications of the HER2CLIMB-05 Trial Data in HER2+ Breast Cancer

Highlighting the FDA Approval of Maintenance Tucatinib-Based Therapy in Advanced HER2+ Breast Cancer

Spotlighting the Potential Future of Pancreatic Cancer Combination Regimens